[Top][All Lists]
[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
[Gnumed-devel] test results and therapeutic ranges (was Possible develop
From: |
J Busser |
Subject: |
[Gnumed-devel] test results and therapeutic ranges (was Possible development opportunity) |
Date: |
Mon, 13 Sep 2004 13:33:13 -0700 |
Before considering the target range for Patient X with an INR of
2.0-3.0, can we also consider the handling of a drug whose levels can
be measured, and which has a therapeutic range which
- may depend on the indication and/or
- may be changed by the doctor who wants it narrower/higher/lower than "usual"
1) have we a suitable place to keep this patient-specific
information, perhaps linkable to the test, so that when the test
result is reviewed we can easily discern if we are satisfied?
2) table test_results has fields
- val_normal_min
- val_normal_max
- text field val_normal_range
all of the above are meant to hold values provided by the lab
when a lab supplies for example phenytoin/dilantin result of 56 and
provides a numeric or text range of 40-80 do we place that in the
_normal_ field(s) in which case they are no longer _normal_ but
_reference_ ?
maybe it is better to have a separate set of fields in addition to
_normal_ considering that when a biologic test like INR comes back at
1.5, this is abnormally elevated in some people, but it is
subtherapeutic in someone on warfarin
we could therefore add a set of fields prefixed value_therapeutic etc
(or value_rx etc)
could it be a good idea to write a patient's corresponding target
values into the test-result row, either overwriting the lab's
reference range or (if these must be preserved as original
communication) into value_target_min and value_target_max?
I am wondering if this would make querying and reporting faster,
separating patients who will need a change of dosage (needing quicker
contact) from the others? Also, once having written the target info
into the test_result row, the row would remain meaningful even after
a doctor later raises or lowers Patient X's range. I realize that a
within-patient history of changes to target ranges should be
accessible via the audits, but would rather avoid people misjudging
from the INRs that have been running 2.0 - 2.8 that a patient's
target is 2.0 - 3.0 when it is in fact 2.5-3.5, not to mention the
complexity of later trying to assess the quality of anticoagulation
in one's clinic/practice/surgery.
- [Gnumed-devel] test results and therapeutic ranges (was Possible development opportunity),
J Busser <=